Mode
Text Size
Log in / Sign up
N/A N=38 Prevention

Peri-Strips Dry (PSD) Veritas Collagen Matrix Staple Line Reinforcement for Colorectal Surgery

Colorectal Cancer

Enrolled (actual)
38
Serious AEs
7.9%
Results posted
May 2012
Primary outcome: Primary: Number of Participants With Major Colorectal Related Adverse Events: Leak, Stricture and Hemorrhage. — 4 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Staple line reinforcement (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Baxter Healthcare Corporation
Primary completion
Dec 2008

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants With Major Colorectal Related Adverse Events: Leak, Stricture and Hemorrhage.
4

Summary

Purpose of the study is to assess the utility of PSD Veritas as a staple line reinforcement to minimize the risk of leakage during or after colo-rectal surgery.

Eligibility Criteria

Inclusion Criteria

  • Patient must comply with follow-up evaluations
  • Patient or representative must provide informed consent prior to enrollment
  • Patient scheduled for elective surgical excision of the left, anterior or low anterior colon
  • Patient must meet all criteria and be eligible to have open or laparoscopic colorectal surgery with primary anastomosis at one location

Exclusion Criteria

  • Crohns disease
  • Emergency colorectal surgery for trauma, obstruction, ischemic bowel, perforated diverticulum and all other emergent diagnosis.
  • Patients who have not had mechanical bowel preparation
  • Patients with known documented sensitivity/allergy to bovine material
  • Severe radiation damage to tissue
  • Carcinomatosis or stage IV cancer
  • BMI is 35 or greater
  • Cancer at primary anastomosis site that cannot be excised
  • Patients who require an ileo rectal anastomosis
  • Surgery anticipated to include jejunostomy pouch
  • Anticipated diverting stoma
  • No anti adhesive barrier can be used around anastomotic site
  • No multiple circular anastomosis
  • Surgeons discretion to exclude any patient he/she feels would not have a safe anastomosis
  • Patient life expectacny less than follow-up timeframe of study
  • Pregnancy
  • Patients currently enrolled in a study that competes for the same patient population
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00559013). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search